Prioritization of Mur family drug targets against A. baumannii and identification of their homologous proteins through molecular phylogeny, primary sequence, and structural analysis

Gizachew Muluneh Amera1, Rameez Jabeer Khan1, Rajat Kumar Jha1, Amita Pathak2, Jayaraman Muthukumaran1, Amit Kumar Singh1
1Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, India
2Department of Chemistry, Indian Institute of Technology, New Delhi, India

Tóm tắt

The World Health Organization (WHO) report stated that Acinetobacter baumannii had been classified as one of the most important pathogenic bacteria causing nosocomial infection in hospital patients due to multi-drug resistance (MDR). It is vital to find out new bacterial drug targets and annotated their structure and function for the exploration of new anti-bacterial agents. The present study utilized a systematic route to prioritize the potential drug targets that belong to Mur family of Acinetobacter baumannii and identify their homologous proteins using a computational approach such as sequence similarity search, multiple sequence alignment, phylogenetic analysis, protein sequence, and protein structure analysis. From the results of protein sequence analysis of eight Mur family proteins, they divided into three main enzymatic classes namely transferases (MurG, MurA and MraY), ligases (MurC, MurD, MurE, and MurF), and oxidoreductase (MurB). Based on the results of intra-comparative protein sequence analysis and enzymatic classification, we have chosen MurB, MurE, and MurG as the prioritized drug targets from A. baumannii and subjected them for further detailed studies of inter-species comparison. This inter-species comparison help us to explore the sequential and structural properties of homologous proteins in other species and hence, opens a gateway for new target identification and using common inhibitor for different bacterial species caused by various diseases. The pairwise sequence alignment results between A. baumannii’s MurB with A. calcoaceticus’s MurB, A. baumannii’s MurE with A. seifertii’s MurE, and A. baumannii’s MurG with A. pittii’s MurG showed that every group of the proteins are highly similar with each other and they showed sequence identity of 95.7% and sequence similarity of 97.2%. Together with the results of secondary and three-dimensional structure predictions explained that three selected proteins (MurB, MurE, and MurG) from A. baumannii and their related proteins (AcMurB, AsMurE, and ApMurG) belong to mixed αβ class and they are very similar.

Tài liệu tham khảo

Almasaudi SB (2018) Acinetobacter spp. as nosocomial pathogens: EPIDEMIOLOGY and resistance features. Saudi J Biol Sci 25(3):586–596 Peleg AY, Seifert H, Paterson DL (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21(3):538–582 Doughari HJ, Ndakidemi PA, Human IS, Benade S (2009) The ecology, biology and pathogenesis of Acinetobacter spp.: an overview . Microbes Environ 1103150282-1103150282 Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B (2017) Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges. Clin Microbiol Rev 30(1):409–447. https://doi.org/10.1128/cmr.00058-16 Durante-Mangoni E, Utili R, Zarrilli R (2014) Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date. Future Microbiol 9(6):773–789. https://doi.org/10.2217/fmb.14.34 Shrivastava SR, Shrivastava PS, Ramasamy J (2018) World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. J Med Soc 32(1):76 Amera GM, Khan RJ, Pathak A, Kumar A, Singh AK (2019) Structure based in-silico study on UDP-N-acetylmuramoyl-L-alanyl-D-glutamate-2,6-diaminopimelate ligase (MurE) from Acinetobacter baumannii as a drug target against nosocomial infections. Informatics in Medicine Unlocked 16. doi:https://doi.org/10.1016/j.imu.2019.100216 Moraes GL, Gomes GC, Monteiro de Sousa PR, Alves CN, Govender T, Kruger HG, Maguire GE, Lamichhane G, Lameira J (2015) Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development. Tuberculosis (Edinb) 95(2):95–111. https://doi.org/10.1016/j.tube.2015.01.006 Benson TE, Walsh CT, Hogle JM (1996) The structure of the substrate-free form of MurB, an essential enzyme for the synthesis of bacterial cell walls. Structure 4(1):47–54 Gordon E, Flouret B, Chantalat L, van Heijenoort J, Mengin-Lecreulx D, Dideberg O (2001) Crystal structure of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: meso-diaminopimelate ligase from Escherichia coli. J Biol Chem 276(14):10999–11006 Ziegler K, Diener A, Herpin C, Richter R, Deutzmann R, Lockau W (1998) Molecular characterization of cyanophycin synthetase, the enzyme catalyzing the biosynthesis of the cyanobacterial reserve material multi-L-arginyl-poly-L-aspartate (cyanophycin). Eur J Biochem 254(1):154–159. https://doi.org/10.1046/j.1432-1327.1998.2540154.x Al-Dabbagh B, Henry X, Ghachi ME, Auger G, Blanot D, Parquet C, Mengin-Lecreulx D, Bouhss A (2008) Active site mapping of MraY, a member of the polyprenyl-phosphate N-acetylhexosamine 1-phosphate transferase superfamily, catalyzing the first membrane step of peptidoglycan biosynthesis. Biochemistry 47(34):8919–8928 Fakhar Z, Naiker S, Alves CN, Govender T, Maguire GE, Lameira J, Lamichhane G, Kruger HG, Honarparvar B (2016) A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis. J Biomol Struct Dyn 34(11):2399–2417 Amera GM, Khan RJ, Pathak A, Jha RK, Muthukumaran J, Singh AK (2020) Computer aided ligand based screening for identification of promising molecules against enzymes involved in peptidoglycan biosynthetic pathway from Acinetobacter baumannii. Microbial Pathogenesis 147:104205. https://doi.org/10.1016/j.micpath.2020.104205 Sosa EJ, Burguener G, Lanzarotti E, Defelipe L, Radusky L, Pardo AM, Marti M, Turjanski AG, Fernández Do Porto D (2018) Target-pathogen: a structural bioinformatic approach to prioritize drug targets in pathogens. Nucleic Acids Res 46(D1):D413–d418. https://doi.org/10.1093/nar/gkx1015 Ramos PIP, Fernández Do Porto D, Lanzarotti E, Sosa EJ, Burguener G, Pardo AM, Klein CC, Sagot MF, de Vasconcelos ATR, Gales AC, Marti M, Turjanski AG, Nicolás MF (2018) An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets. Scientific reports 8(1):10755. https://doi.org/10.1038/s41598-018-28916-7 Hossain T, Kamruzzaman M, Choudhury TZ, Mahmood HN, Nabi A, Hosen MI (2017) Application of the subtractive genomics and molecular docking analysis for the identification of novel putative drug targets against Salmonella enterica subsp. enterica serovar Poona. BioMed Res Int 2017:3783714 doi:https://doi.org/10.1155/2017/3783714 Uddin R, Jamil F (2018) Prioritization of potential drug targets against P. aeruginosa by core proteomic analysis using computational subtractive genomics and protein-protein interaction network. Comput Biol Chem 74:115–122. https://doi.org/10.1016/j.compbiolchem.2018.02.017 Gao Z, Li H, Zhang H, Liu X, Kang L, Luo X, Zhu W, Chen K, Wang X, Jiang H (2008) PDTD: a web-accessible protein database for drug target identification. BMC Bioinformatics 9:104. https://doi.org/10.1186/1471-2105-9-104 Gasteiger E, Hoogland C, Gattiker A, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. In: The proteomics protocols handbook. Springer, pp 571-607 Letunic I, Doerks T, Bork P (2014) SMART: recent updates, new developments and status in 2015. Nucleic Acids Res 43(D1):D257–D260 Yu NY, Wagner JR, Laird MR, Melli G, Rey S, Lo R, Dao P, Sahinalp SC, Ester M, Foster L (2010) PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26(13):1608–1615 Rice P, Longden I, Bleasby A (2000) EMBOSS: the European molecular biology open software suite. Elsevier current trends, Kurata H, Sugimoto Y (2018) Improved kinetic model of Escherichia coli central carbon metabolism in batch and continuous cultures. J Biosci Bioeng 125(2):251–257 Bhat AH, Mondal H, Chauhan JS, Raghava GP, Methi A, Rao A (2012) ProGlycProt: a repository of experimentally characterized prokaryotic glycoproteins. Nucleic Acids Res 40(D1):D388–D393 Deng W, Wang C, Zhang Y, Xu Y, Zhang S, Liu Z, Xue Y (2016) GPS-PAIL: prediction of lysine acetyltransferase-specific modification sites from protein sequences. Scientific reports 6:39787 Kumar S, Stecher G, Li M, Knyaz C, Tamura K (2018) MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 35(6):1547–1549 Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic acids research 25(17):3389–3402. https://doi.org/10.1093/nar/25.17.3389 Gupta A, Deshpande A, Amburi JK, Sabarinathan R, Senthilkumar R, Sekar K (2009) CSSP (Consensus Secondary Structure Prediction): a web-based server for structural biologists. Journal of Applied Crystallography 42(2):336–338 Amera GM, Khan RJ, Pathak A, Jha RK, Muthukumaran J, Singh AK (2019) Screening of Promising molecules against MurG as drug target in multi-drug-resistant-acinetobacter baumannii—insights from comparative protein modeling, molecular docking and molecular dynamics simulation. J Biomol Struct Dyn:1–37. https://doi.org/10.1080/07391102.2019.1700167 Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, Heer FT, de Beer TA P, Rempfer C, Bordoli L, Lepore R, Schwede T (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic acids research 46 (W1):W296-W303. doi:10.1093/nar/gky427 %J Nucleic Acids Research Krieger E, Joo K, Lee J, Lee J, Raman S, Thompson J, Tyka M, Baker D, Karplus K (2009) Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8. Proteins 77(S9):114–122 Luthy R, Bowie JU, Eisenberg D (1992) Assessment of protein models with three-dimensional profiles. Nature 356(6364):83–85. https://doi.org/10.1038/356083a0 Laskowski RA, Rullmann JAC, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8(4):477–486 Colovos C, Yeates TO (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein 2(9):1511–1519. https://doi.org/10.1002/pro.5560020916 Pontius J, Richelle J, Wodak SJ (1996) Deviations from standard atomic volumes as a quality measure for protein crystal structures. J Mol Biol 264(1):121–136. https://doi.org/10.1006/jmbi.1996.0628 DeLano WL (2002) The PyMOL molecular graphics system. http://www pymol org Li Z, Ye Y, Godzik A (2006) Flexible Structural Neighborhood--a database of protein structural similarities and alignments. Nucleic Acids Res 34 (Database issue):D277-D280. doi:https://doi.org/10.1093/nar/gkj124 Muthukumaran J, Manivel P, Kannan M, Jeyakanthan J, Krishna R (2011) A framework for classification of antifreeze proteins in over wintering plants based on their sequence and structural features. J Bioinformat Sequence Anal 3(4):70–88 Sivakumar K, Balaji S (2007) In silico characterization of antifreeze proteins using computational tools and servers. Journal of Chemical Sciences 119(5):571–579 Sterling T, Irwin JJ (2015) ZINC 15—ligand discovery for everyone. J Chem Inform Modeling 55(11):2324–2337. https://doi.org/10.1021/acs.jcim.5b00559 Tiwari V (2019) Post-translational modification of ESKAPE pathogens as a potential target in drug discovery. Drug discovery today 24(3):814–822